Kevin C. Halling

13.6k total citations
193 papers, 9.7k citations indexed

About

Kevin C. Halling is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Kevin C. Halling has authored 193 papers receiving a total of 9.7k indexed citations (citations by other indexed papers that have themselves been cited), including 81 papers in Oncology, 77 papers in Surgery and 69 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Kevin C. Halling's work include Genetic factors in colorectal cancer (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers) and Cancer Genomics and Diagnostics (28 papers). Kevin C. Halling is often cited by papers focused on Genetic factors in colorectal cancer (37 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (33 papers) and Cancer Genomics and Diagnostics (28 papers). Kevin C. Halling collaborates with scholars based in United States, Canada and United Kingdom. Kevin C. Halling's co-authors include Benjamin R. Kipp, Stephen N. Thibodeau, Gregory J. Gores, Emily G. Barr Fritcher, Lewis R. Roberts, Robert B. Jenkins, Lawrence J. Burgart, Thomas J. Sebo, Amy C. Clayton and Amy J. French and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Gastroenterology.

In The Last Decade

Kevin C. Halling

188 papers receiving 9.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Kevin C. Halling United States	57	4.3k	4.2k	2.9k	2.9k	2.1k	193	9.7k
Mitesh J. Borad United States	44	5.5k 1.3×	3.9k 0.9×	2.4k 0.8×	1.2k 0.4×	4.3k 2.0×	340	10.9k
Ruth L. Katz United States	46	3.5k 0.8×	2.1k 0.5×	2.1k 0.7×	2.0k 0.7×	3.3k 1.5×	212	9.3k
Dung T. Le United States	49	8.5k 2.0×	1.9k 0.4×	3.0k 1.0×	1.8k 0.6×	1.9k 0.9×	197	11.2k
S. Pilotti Italy	54	4.0k 0.9×	1.6k 0.4×	2.8k 1.0×	1.5k 0.5×	3.1k 1.4×	175	9.2k
Yoshihiro Matsuno Japan	59	5.2k 1.2×	2.0k 0.5×	5.6k 1.9×	2.3k 0.8×	2.7k 1.2×	381	13.0k
Neal S. Goldstein United States	52	2.9k 0.7×	2.6k 0.6×	2.1k 0.7×	2.6k 0.9×	710 0.3×	164	7.9k
Zoran Gatalica United States	55	4.8k 1.1×	1.8k 0.4×	3.3k 1.1×	2.1k 0.7×	3.3k 1.6×	328	10.9k
Vincent T.H.B.M. Smit Netherlands	56	3.8k 0.9×	1.5k 0.4×	1.8k 0.6×	1.8k 0.6×	2.7k 1.3×	200	12.0k
Christopher Poremba Germany	54	2.5k 0.6×	1.3k 0.3×	2.2k 0.7×	1.3k 0.5×	3.0k 1.4×	166	7.7k
Peter B. Illei United States	48	2.7k 0.6×	1.6k 0.4×	3.9k 1.3×	688 0.2×	2.7k 1.2×	151	8.3k

Countries citing papers authored by Kevin C. Halling

Since Specialization

Citations

This map shows the geographic impact of Kevin C. Halling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin C. Halling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin C. Halling more than expected).

Fields of papers citing papers by Kevin C. Halling

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin C. Halling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin C. Halling. The network helps show where Kevin C. Halling may publish in the future.

Co-authorship network of co-authors of Kevin C. Halling

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin C. Halling. A scholar is included among the top collaborators of Kevin C. Halling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin C. Halling. Kevin C. Halling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tekin, Burak, Andrew L. Folpe, Surendra Dasari, et al.. (2025). TFE3-rearranged ossifying fibromyxoid tumors are uniquely negative for glycoprotein non-metastatic melanoma protein B: A study of 13 TFE3-rearranged mesenchymal tumors. Human Pathology. 157. 105768–105768. 2 indexed citations

Pitel, Beth A., Saba Alvand, Carlos Sosa, et al.. (2025). Evaluation of Atypical Fluorescence in Situ Hybridization Findings by RNA Sequencing. Journal of Molecular Diagnostics. 27(11). 1098–1114.

Dehner, Carina, Emma F. Johnson, Michael Camilleri, et al.. (2024). Fusion‐driven cutaneous and superficial mesenchymal and adnexal tumors—A clinicopathologic and molecular study of 15 cases, including a novel case of ACTB::ZMIZ2‐rearranged adnexal carcinoma. Journal of Cutaneous Pathology. 51(7). 538–548. 4 indexed citations

Ulici, Veronica, Jason L. Hornick, Jessica L. Davis, et al.. (2023). Extraenteric Malignant Gastrointestinal Neuroectodermal Tumor—A Clinicopathologic and Molecular Genetic Study of 11 Cases. Modern Pathology. 36(7). 100160–100160. 9 indexed citations

Dehner, Carina, Stephen M. Broski, Jeanne M. Meis, et al.. (2023). Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases. Modern Pathology. 36(10). 100271–100271. 21 indexed citations

Shah, Kabeer, Jadee Neff, Lori A. Erickson, et al.. (2020). Correlation of novel ALK^ATI with ALK immunohistochemistry and clinical outcomes in metastatic melanoma. Histopathology. 77(4). 601–610. 5 indexed citations

Mansfield, Aaron S., Hongzheng Ren, Shari L. Sutor, et al.. (2018). Contraction of T cell richness in lung cancer brain metastases. Scientific Reports. 8(1). 2171–2171. 65 indexed citations

Graham, Rondell P., Long Jin, Darlene L. Knutson, et al.. (2015). DNAJB1-PRKACA is specific for fibrolamellar carcinoma. Modern Pathology. 28(6). 822–829. 114 indexed citations

Graham, Rondell P., Emily G. Barr Fritcher, Ekaterina Pestova, et al.. (2014). Fibroblast growth factor receptor 2 translocations in intrahepatic cholangiocarcinoma. Human Pathology. 45(8). 1630–1638. 227 indexed citations

10.

Bent, Martin J. van den, Christian Hartmann, Matthias Preusser, et al.. (2013). Interlaboratory comparison of IDH mutation detection. Journal of Neuro-Oncology. 112(2). 173–178. 57 indexed citations

11.

Sethi, Saurabh, Douglas A. Simonetto, Michael B. Campion, et al.. (2012). Comparison of Circulating Endothelial Cell/Platelet Count Ratio to Aspartate Transaminase/Platelet Ratio Index for Identifying Patients with Cirrhosis. Journal of Clinical and Experimental Hepatology. 2(1). 19–26. 1 indexed citations

12.

Kipp, Benjamin R., Emily G. Barr Fritcher, Amy C. Clayton, et al.. (2010). Comparison of KRAS Mutation Analysis and FISH for Detecting Pancreatobiliary Tract Cancer in Cytology Specimens Collected During Endoscopic Retrograde Cholangiopancreatography. Journal of Molecular Diagnostics. 12(6). 780–786. 55 indexed citations

13.

Voss, Jesse S., Benjamin R. Kipp, Kevin C. Halling, et al.. (2009). Fluorescence in Situ Hybridization Testing Algorithm Improves Lung Cancer Detection in Bronchial Brushing Specimens. American Journal of Respiratory and Critical Care Medicine. 181(5). 478–485. 19 indexed citations

14.

Kipp, Benjamin R., Mihaela Tănăsescu, Sandra C. Bryant, et al.. (2009). Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer. Journal of Molecular Diagnostics. 11(2). 148–154. 24 indexed citations

15.

Björnsson, Einar, Felicity Enders, Emily G. Barr Fritcher, et al.. (2009). Long-Term Outcomes of Positive Fluorescence in Situ Hybridization Tests in Primary Sclerosing Cholangitis. Hepatology. 51(1). 174–180. 126 indexed citations

16.

Prasad, Ganapathy A., Kenneth K. Wang, Kevin C. Halling, et al.. (2008). Utility of Biomarkers in Prediction of Response to Ablative Therapy in Barrett's Esophagus. Gastroenterology. 135(2). 370–379. 51 indexed citations

17.

Lewis, Jason S., Rhett P. Ketterling, Kevin C. Halling, et al.. (2005). Analysis of Intratumoral Heterogeneity and Amplification Status in Breast Carcinomas With Equivocal (2+) HER-2 Immunostaining. American Journal of Clinical Pathology. 124(2). 273–281. 15 indexed citations

18.

Halling, Kevin C.. (2003). Vysis^®UroVysion for the detection of urothelial carcinoma. Expert Review of Molecular Diagnostics. 3(4). 507–519. 42 indexed citations

19.

Dong, X., Ratnam S. Seelan, Kazuhiro Taniguchi, et al.. (2000). Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling (vol 26, pg 146, 2000). Data Archiving and Networked Services (DANS). 3 indexed citations

20.

Warschaw, Karen E., John N. Eble, Antoinette F. Hood, Stephen E. Wolverton, & Kevin C. Halling. (1997). The Muir‐Torre syndrome in a black patient with AIDS: histopathology and molecular genetic studies. Journal of Cutaneous Pathology. 24(8). 511–518. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact